Gary Crowley

Background

About Gary Crowley

AbbVie In Ireland - When AbbVie was formed in 2013, we seized a rare opportunity: to build on Abbott’s 125-year experience and heritage in health by infusing the agility, passion and focus of a start-up business. With patients at the heart of all we strive for, we are proud that AbbVie in Ireland delivers world-class discovery, production and supply of critical medicines. We’re a modern biopharmaceutical business with a significant footprint in Ireland that’s focused on novel and breakthrough therapies for tough-to-treat diseases and unmet medical needs, with a reputation for quality. AbbVie is spread across five sites in Ireland. Alongside three manufacturing facilities in Sligo & Cork, two offices in Dublin serve the needs of the company’s Commercial & Operations activities. Our company creates new medicines for chronic, serious health issues by combining advanced science with deep knowledge of diseases. We harness Irish expertise in complex chemical and biological research, testing discoveries through clinical trials as well as manufacturing many of our medicines and delivery devices here in Ireland. In this way, Ireland contributes to every part of the medicine discovery process before our commercial team works to make these new treatments rapidly accessible to Irish patients. ABBVIE CORK - The company’s plant in Cork, is a modern ‘bulk tablet’ finish facility which manufactures solid and capsule formulations. Innovative new technologies, in combination with the depth of expertise that exists within the local workforce, has allowed those based at ABBVIE CORK to develop and deliver products and processes to support AbbVie’s wider global needs. These range from small scale clinical trial supply to large scale commercial manufacturing. As Site Director - I am proud to lead a highly skilled workforce, delivering a consistent stream of innovative medicines that solve serious health issues and have a remarkable impact on people’s lives. Gary Crowley